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The brain contains a large variety of projection neurons with different functional
properties. The functional properties of projection neurons arise from their connectivity
with other neurons and their molecular composition. We describe a novel tool for
obtaining the gene expression profiles of projection neurons that are anatomically defined
by the location of their soma and axon terminals. Our tool utilizes adeno-associated
virus serotype 9 (AAV9), which we found to retrogradely transduce projection neurons
after injection at the site of the axon terminals. We used AAV9 to express Enhanced
Green Fluorescent Protein (EGFP)-tagged ribosomal protein L10a (EGFP-L10a), which
enables the immunoprecipitation of EGFP-tagged ribosomes and associated mRNA
with a method known as Translating Ribosome Affinity Purification (TRAP). To achieve
high expression of the EGFP-L10a protein in projection neurons, we placed its
expression under control of a 1.3 kb alpha-calcium/calmodulin-dependent protein
kinase II (Camk2a) promoter. We injected the AAV9-Camk2a-TRAP virus in either the
hippocampus or the bed nucleus of the stria terminalis (BNST) of the mouse brain.
In both brain regions the 1.3 kb Camk2a promoter did not confer complete cell-
type specificity around the site of injection, as EGFP-L10a expression was observed
in Camk2a-expressing neurons as well as in neuronal and non-neuronal cells that
did not express Camk2a. In contrast, cell-type specific expression was observed
in Camk2a-positive projection neurons that were retrogradely transduced by AAV9-
Camk2a-TRAP. Injection of AAV9-Camk2a-TRAP into the BNST enabled the use of
TRAP to collect ribosome-bound mRNA from basal amygdala projection neurons that
innervate the BNST. AAV9-Camk2a-TRAP provides a single-virus system that can be
used for the molecular profiling of anatomically defined projection neurons in mice and
other mammalian model organisms. In addition, AAV9-Camk2a-TRAP may enable the
discovery of protein synthesis events that support information storage in projection
neurons.
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Introduction
Projection neurons are responsible for the transmission of
information between brain regions, and thereby play a central
role in many physiological and pathophysiological processes in
the brain. The classification of projection neurons is traditionally
based on the location of their soma and their axon terminals. In
addition to their anatomical heterogeneity, projection neurons
are also heterogeneous at the molecular level (Arlotta et al.,
2005; Sugino et al., 2006; Doyle et al., 2008; Heiman et al., 2008;
Zeisel et al., 2015). A deeper understanding of this molecular
heterogeneity can elucidate mechanisms by which projection
neurons process and store information, and identify therapeutic
targets for brain disorders that impact projection neurons (for
example Shepherd, 2013). Achieving this will require improved
methods that enable efficient molecular profiling of the large
variety of projection neurons in the brain.
Different classes of projection neurons that project to
different brain regions can be intermingled at the level of their
soma. In addition, projection neurons are usually intermingled
with other cell types. This complex cellular environment makes
it challenging to collect biomolecules (for example DNA, RNA,
or proteins) from a single class of projection neurons. Three
types of methods are currently used to address this challenge
(Okaty et al., 2011). First, samples from single projection neurons
can be collected by aspiration through a micro-pipette or by
laser-capture microdissection (Van Gelder et al., 1990; Lambolez
et al., 1992; Kamme et al., 2003). Second, projection neurons
from a single defined class can be collected by dissociating
cells from brain tissue followed by sorting using a fluorescent
reporter protein or a surface protein that is exclusively expressed
within that class of projection neurons (Arlotta et al., 2005;
Sugino et al., 2006; Dugas et al., 2008). Third, an epitope-
tag can be exclusively expressed within a single class of
projection neurons. By attaching the epitope-tag to a protein
that binds to a group of biomolecules, for example a RNA-
binding protein, immunoprecipitation can be used to collect
these biomolecules from homogenized brain tissue (Doyle et al.,
2008; Heiman et al., 2008; Sanz et al., 2009; Ekstrand et al.,
2014).
Here, we present a novel viral tool for the molecular profiling
of projection neurons that are anatomically defined by the
location of their soma and axon terminals. Specifically, we
developed a retrograde virus that expresses an epitope-tagged
ribosomal protein. Injection of this virus at the site of the
axon terminals results in expression of epitope-tagged ribosomes
in retrogradely transduced projection neurons. After dissecting
and homogenizing the brain region that contains the soma of
these retrogradely transduced projection neurons, the epitope-
tagged ribosomal proteins and associatedmRNA can be collected
using the Translating Ribosome Affinity Purification (TRAP)
method (Heiman et al., 2008). We show that our viral tool
can target various types of projection neurons with different
locations of soma and axon terminals, and demonstrate its
utility by collecting mRNA from basal amygdala projection
neurons that innervate the bed nucleus of the stria terminalis
(BNST).
Materials and Methods
Animals
All animal procedures were performed in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals and were approved by the Tufts University
Institutional Animal Care and Use Committee. Wild type male
C57BL/6J (JAX Stock Number 000664) and Friend Virus B-
type (FVB; JAX Stock Number 004828) mice were given food
and water ad libitum and were housed three to five animals
per cage until the start of the experiment (8 weeks of age
or older). Mice were kept on a regular light-dark cycle, and
all experimental manipulations were done during the light
phase. For this study a total of 10 mice were used in three
experiments. Experiment 1, intrahippocampal adeno-associated
virus (AAV) injection followed by immunohistochemistry: 3
C57BL/6J mice and 1 FVB mouse. Experiment 2, intra-BNST
AAV injection followed by immunohistochemistry: 3 C57BL/6J
mice. Experiment 3, intra-BNST AAV injection followed by
TRAP: 3 C57BL/6J mice.
Virus Production
Construct cloning and packaging of adeno-associated virus
serotype 9 (AAV9)-alpha-calcium/calmodulin-dependent
protein kinase II (Camk2a)-TRAP was performed by Virovek.
The Enhanced Green Fluorescent Protein (EGFP)-L10a fusion
protein coding sequence from pLD53.SC.EGFP-L10a (gift from
Nathaniel Heintz, Rockefeller University) was cloned into a
plasmid containing a 1.3 kb fragment of the mouse Camk2a
promoter (Dittgen et al., 2004) to create a Camk2a-TRAP
construct (Figure 1A). The construct was packaged into an AAV
vector containing AAV2 inverted terminal repeats (ITRs) and
AAV9 capsid protein (AAV9-Camk2a-TRAP). Viral titer was
2.18 × 1013 viral genomes/ml. The Camk2a promoter sequence
in AAV9-Camk2a-TRAP was verified using an ABI 3130XL
Automated DNA Sequencer (Life Technologies) at the Tufts
University Core Facility.
Stereotaxic Surgery
Mice were anesthetized with isoflurane, held in a stereotaxic
apparatus (Kopf), and bilaterally injected with AAV9-Camk2a-
TRAP in the hippocampus (1000 nl; AP −1.45 mm, ML ± 1.6
mm, DV −1.6 mm), or the BNST (150 nl; AP + 0.65, ML ±
1.00, DV −4.25). All coordinates are relative to bregma. After
injection, the needle was left in place for 10 min before slowly
retracting. The incision was sutured, and mice were weighed and
monitored to ensure recovery.
Immunohistochemistry
At 14 days after stereotaxic surgery, mice were anesthetized
with ketamine/xylazine and transcardially perfused with 4%
paraformaldehyde. Brains were extracted, post-fixed in 4%
paraformaldehyde for 24 h, transferred to 30% sucrose for 72 h,
and flash frozen in isopentane. 20 µm coronal sections were
sliced using a cryostat (Leica), and stored in cryoprotectant
at −20◦C until use. For immunolabeling, free-floating sections
were incubated in blocking solution (0.1 M phosphate buffered
Frontiers in Molecular Neuroscience | www.frontiersin.org 2 September 2015 | Volume 8 | Article 56
Cook-Snyder et al. Viral TRAP for projection neurons
FIGURE 1 | Enhanced Green Fluorescent Protein (EGFP)-L10a
expression in the hippocampus and entorhinal cortex after injection
of adeno-associated virus serotype 9 (AAV9)-alpha-calcium/
calmodulin-dependent protein kinase II (Camk2a)-Translating
Ribosome Affinity Purification (TRAP) in the hippocampus. (A) The
AAV9-Camk2a-TRAP virus contains a 1.3 kb Camk2a promoter that drives
expression of EGFP-tagged ribosomal protein L10a. ITR, Inverted terminal
repeat; WPRE, woodchuck hepatitis virus posttranscriptional regulatory
element; hGH polyA, human growth hormone polyA sequence.
(B) AAV9-Camk2a-TRAP was injected into the hippocampus (bregma: −2.18
mm, hippocampus highlighted in green; coronal diagram modified from
Paxinos and Franklin, 2001). (C–F) Injections were done in wild type
C57BL/6J (Bl6) (C–E) or Friend Virus B-type (FVB) (F) mice using three
different dilutions of the virus (1:1, 2.18 × 1013 viral genomes/ml; 1:10, 2.18 ×
1012 viral genomes/ml; 1:100, 2.18 × 1011 viral genomes/ml).
Immunohistochemistry was performed to label EGFP-L10a in the
hippocampus (green). (G) Following AAV9-Camk2a-TRAP injection in the
hippocampus, EGFP-L10a expression was also observed in the entorhinal
cortex (bregma: −2.80 mm, entorhinal cortex highlighted in green). (H–K)
Layers in the entorhinal cortex were delineated using the neuronal marker
NeuN (cyan) and the nuclear marker 4′,6-diamidino-2-phenylindole (DAPI)
(blue) (layers are labeled with roman numerals). Each entorhinal cortex image
shown was obtained from the same brain as the hippocampal image on its left
side. (C–F,H–K) Scale bars 100 µm.
saline, 5% normal goat serum, and 0.25% Triton X-100)
for 1 h at room temperature. Sections were incubated in
blocking solution with the following primary antibodies for
72 h at 4◦C: chicken anti-GFP (1:500, Aves, GFP-1020),
rabbit anti-GFP (1:2000, Invitrogen, A-6455), chicken anti-
MAP2 (1:10,000, Abcam, ab5392), mouse anti-neurofilament
(1:5000, Abcam, ab24574), rabbit anti-Camk2 (1:2000, Abcam,
ab52476), mouse anti-GAD67 (1:10,000, Millipore, MAB5406),
chicken anti-GFAP (1:2000, Abcam, ab4674), mouse anti-
NeuN (1:2000, Millipore, MAB377). The immunohistochemical
staining patterns obtained with these antibodies (Figures 1–5)
were in agreement with the known expression patterns of the
corresponding proteins, both at the cellular and subcellular
level, supporting the specificity of these antibodies. Sections
were incubated in the following secondary antibodies for 2 h
at room temperature (all from Jackson ImmunoResearch):
goat anti-chicken Dylight488 (1:500) or Cy3 (1:1000), goat
anti-rabbit Dylight488 (1:1000) or Cy3 (1:2000), goat anti-
mouse Dylight647 (1:500). Sections were mounted to glass
slides using Prolong Gold Anti-Fade Reagent containing
DAPI (Invitrogen), coverslipped, and stored at 4◦C until
imaging.
Image Collection and Analysis
A confocal laser-scanning microscope was used for all image
acquisition (Nikon A1R), except for Figure 6C where a
wide-field epifluorescence microscope was used (Nikon E800).
Confocal image stacks were collected with a 2 µm step using
10×, 20×, or 60× objectives. The settings for PMT, laser
power, gain, and offset were identical between experimental
groups.
Fear Conditioning
At 14 days after stereotaxic surgery, mice underwent a single
contextual fear conditioning trial in a specialized chamber (H10-
11RTC, 120W × 100D × 120H; Coulbourn Instruments). The
trial lasted 500 s with 2 s, 0.7 mA foot shocks administered
at 198, 278, 358 and 438 s. Freezing behavior was measured
using Actimetrics FreezeFrame software during two intervals
before the first shock (0–60 s, 60–180 s), and during intervals
starting 20 s after each of the four shocks (220–260 s, 300–340 s,
380–420 s, and 460–500 s).
Tissue Dissection for TRAP Analysis
Immediately following fear conditioning, mice were anesthetized
with isoflurane and their brains were promptly removed in
ice-cold dissection buffer (1 × HBSS, 2.5 mM HEPES-KOH,
35 mM glucose, 4 mM NaHCO3). Brains were frozen in liquid
nitrogen, and manually sliced into coronal sections (∼1 mm
thickness) using a sterile scalpel blade. Brain sections were kept
frozen on a cold plate at −10◦C (TCP-2D, Thermoelectrics
Unlimited), and tissue punches were taken from the basal
amygdala using a 24-gauge NIH style neuropunch tool (Fine
Science Tools, 18036-24) under a dissectionmicroscope. Coronal
sections were placed in 4% paraformaldehyde overnight, moved
to 30% sucrose for 24 h, and stained with DAPI. Correct
placement of the basal amygdala punch was confirmed for
the anterior and posterior faces of each coronal slice. For
each mouse, three correctly placed tissue punches (∼1 mm
thick and ∼0.31 mm in diameter) were pooled prior to
immunoprecipitation.
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FIGURE 2 | The 1.3 kb Camk2a promoter does not confer complete cell-type specific expression. (A) AAV9-Camk2a-TRAP was injected into the
hippocampus of wild type C57BL/6J (Bl6) or FVB mice (1:1 viral titer, 2.18 × 1013 viral genomes/ml; images of Bl6 1:10 and Bl6 1:100 are shown in Supplementary
Figure 1). (B,C) Images of the CA1 region of the hippocampus showing immunohistochemical labeling of EGFP-L10a (green), the neuronal somatodendritic marker
MAP2 (red), and the axon marker neurofilament (NF, cyan). (D) Quantification of the percentage of EGFP-L10a cells in the CA1 region that overlap with Camk2a (red),
and GAD67 (cyan) (total number of EGFP-L10a cells analyzed: 1:1 Bl6, n = 479, 1:10 Bl6, n = 247, 1:100 Bl6, n = 27, 1:1 FVB, n = 350). (E,F) Images of the CA1
region showing immunohistochemical labeling of EGFP-L10a (green), Camk2a (red), and GAD67 (cyan). (G) Quantification of the percentage of EGFP-L10a cells in
the CA1 region that overlap with the astrocyte marker GFAP (red), and the neuron marker NeuN (cyan) (total number of EGFP-L10a cells analyzed: 1:1 Bl6, n = 460,
1:10 Bl6, n = 272, 1:100 Bl6, n = 29, 1:1 FVB, n = 427). (H,I) Images of the CA1 region showing immunohistochemical labeling of EGFP-L10a (green), GFAP (red),
and NeuN (cyan). Examples of EGFP-L10a expression in NeuN cells for Bl6 1:1 can be found in Supplementary Figure 2J. (B,C,E,F,H,I) Scale bars 12.5 µm, filled
arrows indicate cells positive for the red channel, open arrows indicate cells positive for the cyan channel, overlay includes DAPI, see Supplementary Figure 2 for the
location of images within the CA1 region.
RNA Collection Using TRAP
Collection of RNA was performed using a modified version of
the TRAP protocol (Heiman et al., 2008), as described previously
(Ainsley et al., 2014; Drane et al., 2014). We have previously
verified that this protocol results in low background when brain
tissue is used from mice that do not express EGFP-L10a (Ainsley
et al., 2014; Drane et al., 2014). Briefly, a monoclonal anti-
GFP antibody from the Monoclonal Antibody Core Facility
at Memorial Sloan-Kettering Cancer Center (purified form of
HtzGFP-19C8) was bound tomagnetic epoxy beads (Invitrogen),
and the beads were treated with bovine serum albumin to reduce
nonspecific binding. For each mouse, three tissue punches were
pooled, homogenized, centrifuged to pellet debris, and incubated
with the beads at 4◦C for 1 h. The supernatant (SN) was saved
and the beads were washed five times with a KCl buffer. Trizol
LS was used to extract RNA from the beads and the SN followed
by back extraction to improve yield. Organic contaminants
were removed with butanol and RNA was precipitated with
isopropanol, NaOAc, and linear acrylamide overnight at−80◦C.
After two washes with 80% EtOH, RNAwas resuspended in 10 ul
of nuclease-free water.
Reverse Transcription and qPCR
RNA samples were treated with DNase to remove potential
contamination with DNA. Expected RNA amounts for each
sample were in the picogram range based on a previous study
(Ainsley et al., 2014). Because of the low expected amounts
of RNA, no RNA was used to perform precise quantification
and RIN analysis of the total amount of RNA. Instead equal
volume amounts were used for each quantitative polymerase
chain reaction (qPCR). Reverse transcription was carried
out using Superscript III (Invitrogen) primarily as described
by the manufacturer with the exception that both random
hexamers and anchored oligo-dT were used for priming.
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FIGURE 3 | AAV9-Camk2a-TRAP retrogradely transduces
Camk2a-positive neurons that project to the hippocampus.
AAV9-Camk2a-TRAP was injected into the hippocampus of wild type
C57BL/6J mice (1:1 viral titer, 2.18 × 1013 viral genomes/ml). (A–C) Images of
the entorhinal cortex (A: highlighted in green) showing immunohistochemical
labeling of EGFP-L10a (green) with various cell-type markers (B: Camk2a,
GAD67; C: GFAP, NeuN). (D–F) Images of the basal amygdala (D: highlighted
in green) showing immunohistochemical labeling of EGFP-L10a (green) with
various cell-type markers (E: Camk2a, GAD67; F: GFAP, NeuN). (B,C,E,F)
Scale bars 6.25 µm, filled arrows indicate cells positive for the red channel,
open arrows indicate cells positive for the cyan channel, overlay includes
DAPI, see Supplementary Figure 3 for the location of images within the
entorhinal cortex and basal amygdala.
qPCR was performed with SYBR green master mix (Applied
Biosystems) on a Mx4000 thermal cycler (Agilent) using
the following primer sequences: Camk2a forward primer,
5′-TTTGAGGAACTGGGAAAGGG-3′; Camk2a reverse
primer, 5′-CATGGAGTC GGACGATATTGG-3′; GFAP
forward primer, 5′-CGGAGACGCATCACCTCTG-3′; GFAP
reverse primer, 5′-AGGGAGTGGAGGAGTCATTCG-3′.
Camk2a/GFAP ratios for both the immunoprecipitate (IP) and
SN fractions were calculated as 2(CTGFAP—CTCamk2a) (CT: qPCR
Cycle Threshold).
Results
AAV9 Retrogradely Transduces Entorhinal Cortex
Neurons that Project to the Hippocampus
We made a construct in which a 1.3 kb fragment of the Camk2a
promoter drives the expression of a fusion protein consisting
of EGFP attached to the N-terminus of the ribosomal protein
L10a (Figure 1A). As the expression of EGFP-L10a can be used
for TRAP (Heiman et al., 2008), we will refer to this construct
as Camk2a-TRAP. To express the Camk2a-TRAP construct
in the brain, we packaged it in an AAV9. After injection of
AAV9-Camk2a-TRAP into the dorsal hippocampus of C56BL/6J
mice, we observed widespread expression of EGFP-L10a in the
hippocampus (Figures 1B,C). This expression was more sparse
when the virus was diluted (Figures 1D,E), and was similar in a
different strain of mice (FVB; Figure 1F).
Since both retrograde transport and anterograde trans-
synaptic transport of AAV9 has been observed in previous
studies (Cearley and Wolfe, 2006, 2007; Masamizu et al., 2011;
Löw et al., 2013; Castle et al., 2014a), we analyzed EGFP-
L10a expression in the entorhinal cortex, a brain region that
has strong reciprocal connections with the hippocampus (van
Groen et al., 2003; van Strien et al., 2009). We observed
EGFP-L10a expression in the entorhinal cortex that, similar
to the hippocampus, was more sparse when the virus was
diluted (Figures 1H–K). Entorhinal cortex expression was
predominantly observed in layer II, with additional expression in
layer III (Figures 1H–K). We observed only sporadic expression
in layers V and VI (data not shown). Most entorhinal cortex
neurons that project to the hippocampus reside in layers II and
III, while most entorhinal cortex neurons that receive input from
hippocampal neurons reside in layers V and VI (van Groen
et al., 2003; van Strien et al., 2009). Therefore, the observed
entorhinal cortex expression pattern indicated that the intra-
hippocampal injected AAV9-Camk2a-TRAP was taken up by
axon terminals of entorhinal cortex projection neurons, and
retrogradely transported to their soma for transcription and
translation of EGFP-L10a.
A 1.3 kb Camk2a Promoter is Insufficient to
Confer Complete Cell-Type Specific Expression
To confirm that EGFP-L10a protein expressed by AAV9-
Camk2a-TRAP is functional, we determined the subcellular
localization of EGFP-L10a. EGFP-L10a protein was present in
the soma and dendrites of CA1 pyramidal neurons, but not in
axons (Figures 2A–C, Supplementary Figures S1A–C, S2A–E),
in agreement with the previously reported somatodendritic
localization of ribosomes in neurons (Bodian, 1965; Steward and
Levy, 1982; Ostroff et al., 2002). To verify whether the 1.3 kb
Camk2a promoter restricted EGFP-L10a expression to neurons
that express endogenous Camk2a, we compared EGFP-L10a
expression in the hippocampal CA1 region with the expression of
endogenous Camk2a protein and several other cell type markers.
This revealed that in the CA1 region the majority of EGFP-
L10a expressing cells were Camk2a-expressing CA1 pyramidal
neurons (Figures 2D–F, Supplementary Figures S1D,E, S2F–I).
However, a fraction of EGFP-L10a expression was detected
in CA1 cells that do not express Camk2a, including GAD67-
positive interneurons (Figures 2D–F, Supplementary Figures
S1D,E, S2F–I), and GFAP-positive astrocytes (Figures 2G–I,
Supplementary Figures S1F,G, S2J–M). This lack of complete
cell-type specificity was observed in both C57BL/6J and FVB
mice, and when 10× and 100× diluted virus was injected in
C57BL/6J mice (Figures 2D,G). To ensure that the lack of cell-
type specificity was not the result of one or more mutations
in the 1.3 kb Camk2a promoter, we sequenced the promoter.
Frontiers in Molecular Neuroscience | www.frontiersin.org 5 September 2015 | Volume 8 | Article 56
Cook-Snyder et al. Viral TRAP for projection neurons
FIGURE 4 | EGFP-L10a expression in the bed nucleus of the stria terminalis (BNST) after injection of AAV9-Camk2a-TRAP in the BNST. (A)
AAV9-Camk2a-TRAP was injected into an area containing the anterodorsal, anterolateral, and oval subdivisions of the BNST of wild type C57BL/6J mice (1:1 viral
titer, 2.18 × 1013 viral genomes/ml; bregma: 0.26 mm, targeted BNST subdivisions highlighted in green). (B,C) Low magnification images of the BNST showing
immunohistochemical labeling of EGFP-L10a (green) by itself (B), and together with the axon marker NF (cyan) and nuclear marker DAPI (blue) (C). White matter
tracts demarcating the BNST are easily identified with the NF labeling. Scale bar 100 µm. (D–F) High magnification images of the BNST showing
immunohistochemical labeling of EGFP-L10a (green) with various subcellular and cell-type markers [D: neuronal somatodendritic marker MAP2, axon marker NF; (E):
Camk2a, GAD67; (F): GFAP, NeuN]. Scale bars 12.5 µm, filled arrows indicate cells positive for the red channel, open arrows indicate cells positive for the cyan
channel, overlay includes DAPI, see Supplementary Figure 4 for the location of images within the BNST.
This confirmed that the 1289 bp Camk2a promoter sequence
in AAV9-Camk2a-TRAP completely aligns with a 1289 bp
sequence located within the Camk2a promoter region of the
mouse genome (chr18: 60, 924, 430–60, 925, 718, UCSC Dec.
2011 mm10 assembly), with the exception of 1 bp at the location
of a single-nucleotide polymorphism that is common among
mouse strains (dbSNP build 138 rs30301076).
Retrogradely Transduced Projection Neurons are
Camk2a Positive
We next performed cell-type analysis of cells in the entorhinal
cortex that expressed EGFP-L10a after injection of AAV9-
Camk2a-TRAP in the hippocampus. Within the entorhinal
cortex, almost all of the EGFP-L10a expressing cells were
Camk2a-positive neurons, with no EGFP-L10a expression found
in GAD67-positive interneurons and GFAP-positive astrocytes
(Figures 3A–C, Supplementary Figures S3A–C). This pattern
is in agreement with a retrograde transduction of neurons
that project from layers II-III of the entorhinal cortex to
the hippocampus (van Groen et al., 2003; van Strien et al.,
2009), as opposed to passive diffusion of the virus from
the hippocampus to the entorhinal cortex. In case of passive
diffusion, some EGFP-L10a expression would be expected in
GAD67-positive interneurons and GFAP-positive astrocytes
similar to the observed expression pattern around the injection
site in the hippocampus (Figure 2). We also observed EGFP-
L10a expressing cells in the basal amygdala, in agreement with
the existence of Camk2a-expressing neurons that project from
the basal amygdala to the hippocampus (Pitkänen et al., 2000;
McDonald et al., 2002). Accordingly, almost all of the EGFP-
L10a expressing cells in the basal amygdala were Camk2a-
positive neurons, with no EGFP-L10a expression found in
GAD67-positive interneurons and GFAP-positive astrocytes
(Figures 3D–F, Supplementary Figures S3D–F). These results
illustrate the ability of AAV9-Camk2a-TRAP to retrogradely
transduce multiple classes of Camk2a-expressing projection
neurons.
AAV9 Retrogradely Transduces Neurons that
Project to the Bed Nucleus of the Stria Terminalis
To verify that the retrograde transduction capacity of AAV9-
Camk2a-TRAP is not limited to intra-hippocampal injections,
we injected the virus in a second brain region. Injection of AAV9-
Camk2a-TRAP into the BNST (anterodorsal, anterolateral, and
oval subdivisions) resulted in widespread EGFP-L10a expression
around the site of injection (Figures 4A–C, Supplementary
Figures S4A–D). In agreement with its incorporation into
ribosomes, EGFP-L10a expression was somatodendritic without
expression in axons (Figure 4D, Supplementary Figure S4B).
Similar to the hippocampus, EGFP-L10a expression was
not completely cell-type specific. Though many EGFP-L10a
expressing cells around the site of injection were Camk2a-
positive, EGFP-L10a expression was also observed in GAD67-
positive neurons and GFAP-positive astrocytes (Figures 4E,F,
Supplementary Figures S4C,D).
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FIGURE 5 | AAV9-Camk2a-TRAP retrogradely transduces Camk2a-positive neurons that project to the BNST. AAV9-Camk2a-TRAP was injected into the
BNST of wild type C57BL/6J mice (1:1 viral titer, 2.18 × 1013 viral genomes/ml). (A–C) Images of the basal amygdala (A: highlighted in green) showing
immunohistochemical labeling of EGFP-L10a (green) with various cell-type markers [B: Camk2a, GAD67; (C): GFAP, NeuN]. (D–F) Images of the lateral
hypothalamus (D: highlighted in green) showing immunohistochemical labeling of EGFP-L10a (green) with various cell-type markers [E: Camk2a, GAD67; (F): GFAP,
NeuN]. (G–I) Images of the paraventricular thalamic nucleus (G: highlighted in green) showing immunohistochemical labeling of EGFP-L10a (green) with various
cell-type markers [H: Camk2a, GAD67; (I): GFAP, NeuN]. (B,C,E,F,H,I) Scale bars 4 µm, filled arrows indicate cells positive for the red channel, open arrows indicate
cells positive for the cyan channel, overlay includes DAPI, see Supplementary Figure 5 for the location of images within the basal amygdala, lateral hypothalamus,
and paraventricular thalamic nucleus.
We next determined potential retrograde transport of AAV9-
Camk2a-TRAP by analyzing EGFP-L10a expression in three
brain regions known to contain neurons that project to the
BNST: the basal amygdala, the lateral hypothalamus, and
the paraventricular nucleus of the thalamus (Arluison et al.,
1994; Dong et al., 2001a; Li and Kirouac, 2008). In all three
brain regions EGFP-L10a expression was observed (Figure 5,
Supplementary Figure S5), and in all three brain regions EGFP-
L10a expression was cell-type specific and restricted to Camk2a-
expressing neurons (Figure 5, Supplementary Figure S5). Since
the BNST subdivisions surrounding the injection site do not
contain neurons that project to the basal amygdala (Dong et al.,
2001b; Dong and Swanson, 2004, 2006), the observed EGFP-
L10a expression in basal amygdala neurons did not result from
a previously reported trans-synaptic anterograde transport of
AAV9 (Castle et al., 2014a). These data further confirm the
retrograde transduction capacity of AAV9-Camk2a-TRAP.
AAV9-Camk2a-TRAP Enables the Collection of
mRNA from Anatomically Defined Projection
Neurons
To test whether mRNA can be collected from projection neurons
that are retrogradely transduced with AAV9-Camk2a-TRAP,
we injected the virus in the BNST and performed TRAP
analysis of microdissected basal amygdala tissue (Figure 6A).
A critical requirement for the successful application of TRAP
is that the mRNA in the cell-type of interest is bound to
GFP-tagged ribosomes. Since the level of ribosome-association
is expected to increase during increased levels of translation,
and since neuronal activation has been reported to increase
translation (Kelleher et al., 2004; Costa-Mattioli et al., 2009), we
attempted to activate the basal amygdala neurons that project
to the BNST immediately before microdissection of the basal
amygdala. For this we used contextual fear conditioning, which
activates basal amygdala projection neurons (Stanciu et al.,
2001; Reijmers et al., 2007). Intra-BNST injection of AAV9-
Camk2a-TRAP did not prevent the acquisition of conditioned
fear (Figure 6B). The brains were dissected immediately after
a single fear conditioning trial, rapidly frozen, and cut into
coronal sections. The basal amygdala was microdissected using a
tissue puncher, and the correct location of each microdissection
was verified with a microscope (Figure 6C). Basal amygdala
microdissections were processed for TRAP, and mRNA from
both the IP and SN fractions was analyzed with a qPCR of
Camk2a and GFAP. We observed a higher Camk2a/GFAP ratio
in the IP as compared to the SN, in agreement with the
expression of EGFP-L10a in basal amygdala projection neurons
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FIGURE 6 | Collection of ribosome-bound mRNA from basal amygdala neurons that project to the BNST. (A) AAV9-Camk2a-TRAP was injected into the
BNST of wild-type C57BL/6J mice (1:1 viral titer, 2.18 × 1013 viral genomes/ml). 14 days later the mice were subjected to a single fear conditioning trial, which was
immediately followed by collection of tissue punches from the basal amygdala. Tissue punches were subjected to TRAP, which separates mRNA into
immunoprecipitate (IP) and supernatant (SN) fractions using anti-GFP-conjugated magnetic beads. The IP contains mRNA bound to EGFP-L10a containing
ribosomes present in retrogradely transduced basal amygdala projection neurons, while the SN contains mRNA from other sources. (B) Freezing behavior was
determined during fear conditioning (n = 3; ∗∗∗p < 0.001 vs. 60 s by one-way ANOVA plus Newman-Keuls post hoc testing; black arrows indicate footshocks).
(C) Representative image of a basal amygdala tissue punch (white: DAPI; dotted line indicates basal amygdala; scale bar 100 µm). (D) Camk2a and GFAP mRNA
was quantified in the IP and SN fractions by quantitative polymerase chain reaction (qPCR), followed by calculation of the Camk2a/GFAP ratios in these fractions
(n = 3; ∗∗∗p < 0.001 IP vs. SN by paired t-test).
that are Camk2a-positive and GFAP-negative (Figures 5A–C,
6D). These data indicate that AAV9-Camk2a-TRAP enables
the collection of mRNA from anatomically defined projection
neurons.
Discussion
In this study we performed a detailed histological analysis of
mouse brains injected with an AAV9 that expresses EGFP-L10a
under control of a 1.3 kb Camk2a promoter (AAV9-Camk2a-
TRAP). Two conclusions can be drawn from this analysis. First,
the 1.3 kb Camk2a promoter does not confer complete cell-type
specific expression around the site of injection, as we observed
EGFP-L10a expression in cells that do not express endogenous
Camk2a. Second, injection of AAV9-Camk2a-TRAP enables
the expression of EGFP-L10a in projection neurons defined
by their projection target. This expression can be used for
TRAP analysis, as illustrated by the collection of mRNA from
retrogradely transduced neurons that project from the basal
amygdala to the BNST. Employment of AAV9-Camk2a-TRAP
in combination with RNA-Seq should enable the genome-wide
molecular profiling of anatomically defined projection neurons
in mice, as well as other mammalian species (Masamizu et al.,
2011; Löw et al., 2013).
We found that the 1.3 kb Camk2a promoter was insufficient
to confer complete cell-type specific expression of EGFP-L10a
around the site of virus injection in two different brain regions
(hippocampus and BNST). Most EGFP-L10a expression was
observed in Camk2a-expressing neurons, in agreement with
previous studies that employed the 1.3 kb Camk2a promoter
to drive transgene expression in Camk2a-expressing projection
neurons in various brain regions (Dittgen et al., 2004; Nathanson
et al., 2009; Johansen et al., 2010; Lee et al., 2010; Stuber et al.,
2011; Tye et al., 2011; Jennings et al., 2013; Nieh et al., 2015). The
EGFP-L10a expression in hippocampal GABAergic interneurons
observed in our study is in agreement with previous studies that
also reported expression in GABAergic neurons after injection of
AAV containing the 1.3 kb Camk2a promoter (Nathanson et al.,
2009; Johansen et al., 2010; Jennings et al., 2013; Nieh et al., 2015).
Our data clearly establish that the 1.3 kb Camk2a promoter
can drive expression in both neuronal and non-neuronal cells
that are Camk2a-negative. In contrast, we and others previously
found that a transgenic Camk2a promoter of 8.5 kb length is
sufficient to confer cell-type specificity in the CA1 region of
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the hippocampus and in other regions of the brain (Mayford
et al., 1996; Ainsley et al., 2014; Drane et al., 2014). This suggests
that the 8.5 kb Camk2a promoter contains critical regulatory
sequences that are missing in the 1.3 kb Camk2a promoter.
Alternatively, complete cell-type specificity might require some
form of epigenetic regulation that is missing when the Camk2a
promoter is placed in AAV, due to the episomal nature of
the AAV genome in transduced cells. It should be noted that
the ITR region of AAV has been reported to drive expression
in brain cells in the absence of a promoter, though with low
efficiency (Haberman et al., 2000). Therefore, it can not be ruled
out that the ITR in AAV-Camk2a-TRAP may have contributed
to the observed expression of EGFP-L10a in Camk2a-negative
cells. Despite being imperfect as a cell-type specific driver, the
1.3 kb Camk2a promoter is useful for achieving high transgene
expression in projection neurons that are subsequently analyzed
or manipulated outside the sphere of passive virus diffusion. This
can be achieved with the retrograde targeting of the soma, as was
done in this study, or with the anterograde targeting of axons
using a virus that expresses an optogenetic or pharmacogenetic
effector protein combined with local administration of the light
or drug to the axon terminals only (Lee et al., 2010; Stuber et al.,
2011; Tye et al., 2011; Jennings et al., 2013; Stachniak et al., 2014;
Nieh et al., 2015).
The ability of AAV9-Camk2a-TRAP to retrogradely
transduce projection neurons, and subsequently drive expression
of EGFP-L10a in these neurons, opens up the possibility of
collecting ribosome-bound mRNA from anatomically defined
projection neurons. Accordingly, we were able to collect mRNA
from projection neurons defined by the location of their
soma in the basal amygdala and the location of their axon
terminals in the BNST. Three points need to be considered
when employing AAV9-Camk2a-TRAP in future studies. First,
though we were able to target a sufficient number of BA to
BNST projecting neurons for the successful performance of
TRAP, the practical utility of AAV9-Camk2a-TRAP will need
to be validated on a case-by-case basis for each new group
of projection neurons. Depending on the density of axon
terminals, and the efficacy of AAV endocytosis and retrograde
transport, different groups of projection neurons are likely
to express different amounts of EGFP-L10a, and as a result
will be more or less suitable for subsequent TRAP analysis. It
should be noted that a high titer AAV9 preparation appears
essential for the targeting of sufficient numbers of projection
neurons (Figure 1). Even at the highest titer used in our study,
the average number of retrogradely transduced BA neurons
following injection of AAV9-Camk2a-TRAP into the BNST
was less than the average number of retrogradely labeled BA
neurons following injection of the retrograde tracer Cholera
Toxin B into the BNST (∼6.5% for AAV9-Camk2a-TRAP,
Supplementary Figure S5C, vs. ∼23% for Cholera Toxin
B, data not shown). A higher retrograde transduction rate
might be achieved by further increasing the viral titer, and
by injecting more viral solution (at a lower injection rate to
prevent viral spread outside of the target region). Second, the
Camk2a promoter, though not conferring complete cell-type
specificity, does favor expression in Camk2a expressing neurons
(Figure 2). It is therefore unlikely that AAV9-Camk2a-TRAP
can be used for sufficient retrograde targeting of projection
neurons that do not express Camk2a. This can be resolved by
replacing the Camk2a promoter in AAV9-Camk2a-TRAP with
a different promoter that is known to drive high expression
in the projection neurons of interest. Third, it has become
clear that intermingled projection neurons with overlapping
projection targets can have different molecular identities
(McDonald et al., 2012; Jennings et al., 2013; Nieh et al., 2015).
In those cases, the use of our AAV9-Camk2a-TRAP tool might
result in the collection of ribosome-bound mRNA from two
or more classes of projection neurons that have different
molecular profiles. Follow-up experiments that combine a
retrograde tracer with multiplex in situ hybridization could
resolve whether a defined projection pathway is molecularly
heterogeneous.
Our AAV9-Camk2a-TRAP tool bears similarity with a
related tool that is based on the expression of an EGFP-
nanobody tagged ribosomal protein L10a (NBL10: nanobody-
L10a) (Ekstrand et al., 2014). By co-expressing NBL10 and EGFP
in anatomically defined projection neurons using the retrograde
canine adenovirus, ribosomes can be indirectly tagged with
EGFP through binding of EGFP to NBL10. This enabled the
collection of ribosome-bound mRNA from anatomically defined
projection neurons using an immunoprecipitation protocol that
is similar to the one used for TRAP (Ekstrand et al., 2014).
The NBL10 tool requires the injection of two viruses or the
use of a NBL10 transgenic mouse. In contrast, AAV9-Camk2a-
TRAP can be readily employed with a single virus injection
in any mouse model without additional breeding. This will be
especially useful for themolecular profiling of projection neurons
in genetic mouse models for brain disorders. On the other hand,
the dual-component nature of the NBL10/EGFP system enables
an intersectional strategy for achieving a higher level of cell-type
specific targeting. Future studies comparing the two tools side-
by-side will be useful for determining conditions where the use
of one of these tools is preferable. An important consideration
should be that the two tools are based on two different retrograde
viruses, AAV9 vs. canine adenovirus. Though these two viruses
seem to use similar machinery for retrograde axonal transport
in cultured neurons (Salinas et al., 2009; Castle et al., 2014b),
it is possible that they have different retrograde transduction
properties in vivo. A future study that directly compares the
in vivo retrograde transduction efficacies of AAV9 with canine
adenovirus, and other retrograde viruses such as lentivirus
pseudotyped with rabies virus glycoprotein (Mazarakis et al.,
2001), would therefore be extremely useful.
There are two general points of consideration whenmolecular
profiling is done through the employment of epitope-tagged
ribosomal proteins such as EGFP-L10a, NBL10, or other variants
(Heiman et al., 2008; Sanz et al., 2009; Ekstrand et al., 2014). First,
use of an antibody is needed to IP the epitope-tagged ribosomes
and associated mRNA. Since antibodies are rarely completely
specific, some mRNA-protein complexes might be collected
without being associated with an epitope-tagged ribosome.
The resulting non-specific background mRNA signal in the IP
fraction can be filtered out post hoc by focusing on mRNAs
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that are enriched in the IP fraction vs. the SN or input fraction
(Heiman et al., 2008; Sanz et al., 2009; Dougherty et al.,
2010; Ainsley et al., 2014; Drane et al., 2014; Ekstrand et al.,
2014). Second, epitope-tagged ribosomes enable the collection
of translated, but not untranslated, mRNA. As the translational
state of mRNAs can be regulated by neuronal activity (Kelleher
et al., 2004; Costa-Mattioli et al., 2009), it is important to
control the various environmental and internal factors that
could alter the activation state of the projection neurons that
express the epitope-tagged ribosomes. This is illustrated by
previous TRAP studies that observed changes in the pool of
ribosome-boundmRNAwhen the activation state of the neurons
was altered (Heiman et al., 2008; Schmidt et al., 2012; Huang
et al., 2013; Ainsley et al., 2014). In our current study we
controlled the activation state of BA to BNST projecting neurons
by performing TRAP analysis on mice that were sacrificed
at the same time-point after a single fear conditioning trial.
It will be of interest to perform future studies that employ
AAV9-Camk2a-TRAP in separate groups of mice with different
activation states, including mice at baseline. Comparisons
between these groups could identify proteins whose synthesis
is activity-regulated within an anatomically defined class of
projection neurons, which could lead to the discovery of novel
molecular mechanisms that support information storage in these
neurons.
Obtaining a complete molecular profile of a defined class
of projection neurons will require the employment of various
methods, including methods that are not based on epitope-
tagged ribosomes. For example, dissociation of neurons from
brain tissue enables the collection and analysis of all types
of RNA, including untranslated mRNA and non-coding RNA.
Dissociating neurons that are labeled with a retrograde tracer
(Cholera Toxin B, Fluoro-Gold, latex microspheres) enables the
collection of all types of RNA from target-defined projection
neurons (Arlotta et al., 2005; Sugino et al., 2006; Dugas et al.,
2008). However, dissociating neurons from brain tissue causes
the loss of the RNA pool that is located in neuronal processes
such as dendrites, which can contain more than half of the
cellular volume of a neuron (Ulfhake and Kellerth, 1981; Holt
and Schuman, 2013). Two recent studies reported the RNA-
Seq analysis of transcriptomes collected from single neurons
from mouse and human brain (Darmanis et al., 2015; Zeisel
et al., 2015). These single-cell methods enable the molecular
profiling of projection neurons with high specificity, but still
require dissociation of neurons. An alternative to sequencing
RNA collected through epitope-tagging or the dissociation of
neurons is provided by in situ detection of RNA. Highly
multiplexed in situ detection of RNA in neurons has recently
become possible, thereby enabling molecular profiling of
neurons while retaining the precise subcellular localization of
the RNAs within the soma and processes (Lee et al., 2014;
Chen et al., 2015). It remains to be determined whether these
multiplex in situ methods can achieve the same sensitivity
as RNA-Seq for the quantitative detection of low abundance
mRNA.
In conclusion, we report an AAV9-Camk2a-TRAP tool that
can retrogradely transduce projection neurons in the mouse
brain after its injection at the site of axon terminals, resulting
in EGFP-tagged ribosomes in projection neurons defined by
their projection target. This enabled the collection of ribosome-
bound mRNA from basal amygdala neurons that project to the
BNST. As AAV9 has been reported to retrogradely transduce
neurons in rat and monkey brains (Masamizu et al., 2011; Löw
et al., 2013), we anticipate that the AAV9-Camk2a-TRAP tool
can be used for the molecular profiling of anatomically defined
projection neurons in a wide variety of mammalian species.
In addition, future studies can employ AAV9-Camk2a-TRAP
to perform genome-wide analyses of ribosome-bound mRNA
collected from anatomically defined projection neurons after
various experimental manipulations, which might shed light on
protein synthesis events that support information storage in
projection neurons.
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